Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Scott R. Evans, PhD, M.S. (he/him/his)

Professor and Director of the Biostatistics Center
Milken Institute School of Public Health
Rockville, MD, United States

Dr. Scott Evans is a Professor and Founding Chair of the Department of Biostatistics and Bioinformatics and the Director of The Biostatistics Center at Milken Institute School of Public Health of the George Washington University. He is the: Director of the Statistical and Data Management Center for the Antibacterial Resistance Leadership Group (ARLG) funded by NIAID/NIH; the PI of the Coordinating Center for the Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium funded by the NCI/NIH, and the co-PI of the Data Coordinating Center of the Clamp OR Delay among neonates with Congenital Heart Disease (CORD-CHD) clinical trial funded by the NHLBI/NIH. He is the Co-Chair of the Benefit-Risk Balance for Medicinal Products Working Group of the Council for International Organizations of Medical Sciences (CIOMS); Editor of a mini-Series on DSMBs for the NEJM Evidence; a member of an FDA Advisory Committee; and the President-elect of the Society for Clinical Trials (SCT). He is a recipient of the Mosteller Statistician Award, the Zackin Distinguished Collaborative Statistician Award, the Founders Award from the American Statistical Association (ASA), an elected member of the International Statistical Institute (ISI), and is a Fellow of the ASA, SCT, and the Infectious Disease Society of America (IDSA).

Disclosure(s): Abbvie: Advisor/Consultant (); Advantagene: Advisor/Consultant (); Akouos: Advisor/Consultant (); Apellis: Advisor/Consultant (); AstraZenenca: Advisor/Consultant (); BARDA: Advisor/Consultant (); Breast International Group: Advisor/Consultant (); CDC: Grant/Research Support (); Clover: Advisor/Consultant (); DayOneBio: Advisor/Consultant (); Degruyter: Editorial service (); Duke University: Advisor/Consultant (); Eli Lilly: Advisor/Consultant (); FDA: Advisor/Consultant (); Frontier Science Foundation: Board Member (); Genentech: Advisor/Consultant (); GSK: Advisor/Consultant (); Henry Jackson Foundation: Grant/Research Support (); International Drug Development Institute: Advisor/Consultant (); Johson & Johnson: Advisor/Consultant (); Medtronic: Advisor/Consultant (); NIH: Grant/Research Support (); Novartis: Advisor/Consultant (); Pfizer: Advisor/Consultant (); Rakuten: Advisor/Consultant (); Roche: Advisor/Consultant (); Takeda: Advisor/Consultant (); Taylor & Francis: Book royalties (); Teva: Advisor/Consultant (); University of Penn: Advisor/Consultant (); Vir: Advisor/Consultant (); Wake Forest University: Advisor/Consultant (); Washington University: Advisor/Consultant ()

Presentation(s):